TATAA Biocenter launches GrandPerformance assays for expression profiling of single circulating tumor cells
TATAA Biocenter, Europe´s leading provider of genomic services using quantitative real-time PCR (qPCR), launches the GrandPerformance qPCR assays for the profiling of Circulating Tumor Cells. The assays are optimized for single cell sensitivity and the workflow is based on preamplification allowing sensitive and precise measurements of 96 specific expression markers per cell.
28 June 2019
Deep Dive in Hannover
19 June 2019
WHINN 2019 (Odense)
14 June 2019
BioLab | PPNT Gdynia: More than 250 companies